Results 221 to 230 of about 259,609 (290)

Impact of Opioid Limiting Legislation on Prescribing in Adolescent Breast Surgery at a Tertiary Pediatric Hospital. [PDF]

Plast Reconstr Surg Glob Open
Kennedy CC, Qureshi AA, Czerniecki S, Blum KM, Lin SHY, Vasko AJ, Pearson GD, Bjorklund KA, Khansa I, Kirschner RE, Barker JC.   +10 more
europepmc   +1 more source

Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?

Clinical Pharmacology &Therapeutics, EarlyView.
Pediatric drug development has achieved remarkable success in the last 20 years with over 1,000 products studied in pediatric patients. This success has been driven in part by an increased understanding of pediatric disease processes. The aspect that has been largely overlooked is the potential adverse effect of new drugs on pediatric developmental ...
Gilbert J. Burckart, Susan M. Abdel‐Rahman, Gelareh Abulwerdi, Sherbet Samuels, Rebecca Racz, Mohamed A. Mohamoud, Nicholas P. Tatonetti   +6 more
wiley   +1 more source

'I Would Feel Failed By the Medical Community Entirely': Transgender Americans' Calls for Advocacy From Health Professionals in a Care-Restricted World. [PDF]

Health Expect
Wallace K, Reynolds J, Krikorian J, Blasdel G, Byrnes M, Stroumsa D.   +5 more
europepmc   +1 more source

Ten‐Year Public Expenditure Savings Associated with TNF Inhibitor Biosimilars under Australia's Pharmaceutical Benefits Scheme

Clinical Pharmacology &Therapeutics, EarlyView.
Biologic therapies are a major and growing driver of pharmaceutical expenditure globally, with tumor necrosis factor (TNF) inhibitors among the most widely used and costly biologics. In Australia, these therapies are funded through the Pharmaceutical Benefits Scheme (PBS), where biosimilars offer lower cost alternatives; however, the long‐term public ...
Chin Hang Yiu, Bella D. Ianni, Richard O. Day, Jacques Raubenheimer, Christine Y. Lu   +4 more
wiley   +1 more source

Complaints filed with the Veterinary Disciplinary Board in Sweden - a thematic analysis. [PDF]

BMC Vet Res
Svanberg I, Egenvall A, Enlund KB.
europepmc   +1 more source

Digital Transformation of Medicines Regulation in Africa—Perspectives from a Stakeholder Convening

Clinical Pharmacology &Therapeutics, EarlyView.
Regulatory authorities worldwide are developing strategies to integrate artificial intelligence (AI) into the lifecycle of health products, technologies, and medicines. While regulators share goals of improving efficiency, strengthening decision‐making, and protecting public health, their approaches differ according to institutional structures ...
Christelna Reyneke, Boitumelo Semete‐Makokotlela, Varnika Singh, Khanyisile Nkuku, Madelein Terblanche, Ezekiel T Mukanga, Nancy Ngum, Kudakwashe Dandajena, McNeil Chimus Mhango, Paulyne Wairimu, John Mwangi, Dominique Lagrave, Goonaseelan (Colin) Pillai   +12 more
wiley   +1 more source

Federal Policy Changes and Online Diversity, Equity, and Inclusion Content Among US Medical Schools.

JAMA Netw Open
Sreepada S, Ko M.
europepmc   +1 more source

Sex- and gender-based harassment: the toxic substrate of medical professional culture. [PDF]

CMAJ
Patrick K.
europepmc   +1 more source

Application of Virtual Twin PBPK Models in Individuals with Obesity via CYP3A4 Phenotyping Using Endogenous Biomarker Data

Clinical Pharmacology &Therapeutics, EarlyView.
Plasma 4β‐hydroxycholesterol (4β‐OHC) normalized for the levels of its parent cholesterol (4β‐OHC/C) is an endogenous biomarker for hepatic CYP3A4. This study evaluated CYP3A4 activity longitudinally in individuals while their obesity status was changing. 4β‐OHC/C was measured pre‐surgery (n = 54) and 2 years after Roux‐en‐Y gastric bypass (n = 30) and
Nihan Izat, Haribhau Kangne, Rasmus Jansson‐Löfmark, Jens K. Hertel, Amin Rostami‐Hodjegan, Ida Robertsen, Aleksandra Galetin   +6 more
wiley   +1 more source

Barriers to the Implementation of Iran's Clean Air Act: A Policy-Oriented Scoping Review. [PDF]

Environ Health Insights
Bouzarjomehri H, Ehrampoush MH, Ebrahimi AA, Soltanianzadeh Z, Khosravi M, Herandi Y, Mousavi SM, Ranjbar M.   +7 more
europepmc   +1 more source